ArticleFrontiers in pharmacology2022

Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy.

Chen Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.